No post-genetics era in human disease research (original) (raw)

• Martin, J. B. & Gusella, J. F. Huntington's disease. Pathogenesis and management. N. Engl. J. Med. 315, 1267–1276 (1986).
  Article CAS Google Scholar
• Vonsattel, J. P. & DiFiglia, M. Huntington disease. J. Neuropathol. Exp. Neurol. 57, 369–384 (1998).
  Article CAS Google Scholar
• Vonsattel, J. P. et al. Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44, 559–577 (1985).
  Article CAS Google Scholar
• Bhan, A. K., Mizoguchi, E., Smith, R. N. & Mizoguchi, A. Colitis in transgenic and knockout animals as models of human inflammatory bowel disease. Immunol. Rev. 169, 195–207 (1999).
  Article CAS Google Scholar
• Coyle, J. T. An animal model for Huntington's disease. Biol. Psychiatry 14, 251–276 (1979).
  CAS PubMed Google Scholar
• Beal, M. F. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann. Neurol. 31, 119–130 (1992).
  Article CAS Google Scholar
• Brouillet, E., Conde, F., Beal, M. F. & Hantraye, P. Replicating Huntington's disease phenotype in experimental animals. Prog. Neurobiol. 59, 427–468 (1999).
  Article CAS Google Scholar
• Beverstock, G. C. The current state of research with peripheral tissues in Huntington disease. Hum. Genet. 66, 115–131 (1984).
  Article CAS Google Scholar
• Ptacek, L. J. Channelopathies: ion channel disorders of muscle as a paradigm for paroxysmal disorders of the nervous system. Neuromuscul. Disord. 7, 250–255 (1997).
  Article CAS Google Scholar
• Tolleshaug, H., Hobgood, K. K., Brown, M. S. & Goldstein, J. L. The LDL receptor locus in familial hypercholesterolemia: multiple mutations disrupt transport and processing of a membrane receptor. Cell 32, 941–951 (1983).
  Article CAS Google Scholar
• The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971–983 (1993).
• Janus, C. & Westaway, D. Transgenic mouse models of Alzheimer's disease. Physiol. Behav. 73, 873–886 (2001).
  Article CAS Google Scholar
• LaFerla, F. M., Tinkle, B. T., Bieberich, C. J., Haudenschild, C. C. & Jay, G. The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nature Genet. 9, 21–30 (1995).
  Article CAS Google Scholar
• Nakano, Y. et al. Accumulation of murine amyloid β42 in a gene-dosage-dependent manner in PS1 'knock-in' mice. Eur. J. Neurosci. 11, 2577–2581 (1999).
  Article CAS Google Scholar
• Citron, M. et al. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice. Nature Med. 3, 67–72 (1997).
  Article CAS Google Scholar
• Siman, R. et al. Presenilin-1 P264L knock-in mutation: differential effects on Aβ production, amyloid deposition, and neuronal vulnerability. J. Neurosci. 20, 8717–8726 (2000).
  Article CAS Google Scholar
• Moechars, D. et al. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J. Biol. Chem. 274, 6483–6492 (1999).
  Article CAS Google Scholar
• Hackam, A. S., Singaraja, R., Zhang, T., Gan, L. & Hayden, M. R. In vitro evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease. Hum. Mol. Genet. 8, 25–33 (1999).
  Article CAS Google Scholar
• Cooper, J. K. et al. Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture. Hum. Mol. Genet. 7, 783–790 (1998).
  Article CAS Google Scholar
• Persichetti, F. et al. Mutant huntingtin forms in vivo complexes with distinct context-dependent conformations of the polyglutamine segment. Neurobiol. Dis. 6, 364–375 (1999).
  Article CAS Google Scholar
• Li, S. H., Cheng, A. L., Li, H. & Li, X. J. Cellular defects and altered gene expression in PC12 cells stably expressing mutant huntingtin. J. Neurosci. 19, 5159–5172 (1999).
  Article CAS Google Scholar
• Saudou, F., Finkbeiner, S., Devys, D. & Greenberg, M. E. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95, 55–66 (1998).
  Article CAS Google Scholar
• Lunkes, A. & Mandel, J. L. A cellular model that recapitulates major pathogenic steps of Huntington's disease. Hum. Mol. Genet. 7, 1355–1361 (1998).
  Article CAS Google Scholar
• Hackam, A. S. et al. The influence of huntingtin protein size on nuclear localization and cellular toxicity. J. Cell Biol. 141, 1097–1105 (1998).
  Article CAS Google Scholar
• Jackson, G. R. et al. Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons. Neuron 21, 633–642 (1998).
  Article CAS Google Scholar
• Faber, P. W., Alter, J. R., MacDonald, M. E. & Hart, A. C. Polyglutamine-mediated dysfunction and apoptotic death of a Caenorhabditis elegans sensory neuron. Proc. Natl Acad. Sci. USA 96, 179–184 (1999).
  Article CAS Google Scholar
• Kim, M. et al. Mutant huntingtin expression in clonal striatal cells: dissociation of inclusion formation and neuronal survival by caspase inhibition. J. Neurosci. 19, 964–973 (1999).
  Article CAS Google Scholar
• Mangiarini, L. et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493–506 (1996).
  Article CAS Google Scholar
• Gusella, J. F. & MacDonald, M. E. Molecular genetics: unmasking polyglutamine triggers in neurodegenerative disease. Nature Rev. Neurosci. 1, 109–115 (2000).
  Article CAS Google Scholar
• Heath, K. E. et al. Nonmuscle myosin heavy chain iia mutations define a spectrum of autosomal dominant macrothrombocytopenias: may-hegglin anomaly and fechtner, sebastian, epstein, and alport-like syndromes. Am. J. Hum. Genet. 69, 1033–1045 (2001).
  Article CAS Google Scholar
• Girard, T. et al. Genotype–phenotype comparison of the Swiss malignant hyperthermia population. Hum. Mutat. 18, 357–358 (2001).
  Article CAS Google Scholar
• Lia-Baldini, A. S. et al. A molecular approach to dominance in hypophosphatasia. Hum. Genet. 109, 99–108 (2001).
  Article CAS Google Scholar
• Stokowski, R. P. & Cox, D. R. Functional analysis of the neurofibromatosis type 2 protein by means of disease-causing point mutations. Am. J. Hum. Genet. 66, 873–891 (2000).
  Article CAS Google Scholar
• Gutmann, D. H., Geist, R. T., Xu, H., Kim, J. S. & Saporito-Irwin, S. Defects in neurofibromatosis 2 protein function can arise at multiple levels. Hum. Mol. Genet. 7, 335–345 (1998).
  Article CAS Google Scholar
• Davies, S. W. et al. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90, 537–548 (1997).
  Article CAS Google Scholar
• Sathasivam, K. et al. Formation of polyglutamine inclusions in non-CNS tissue. Hum. Mol. Genet. 8, 813–822 (1999).
  Article CAS Google Scholar
• Scherzinger, E. et al. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 90, 549–558 (1997).
  Article CAS Google Scholar
• DiFiglia, M. et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990–1993 (1997).
  Article CAS Google Scholar
• Huang, C. C. et al. Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins. Somat. Cell Mol. Genet. 24, 217–233 (1998).
  Article CAS Google Scholar
• Scherzinger, E. et al. Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology. Proc. Natl Acad. Sci. USA 96, 4604–4609 (1999).
  Article CAS Google Scholar
• Narain, Y., Wyttenbach, A., Rankin, J., Furlong, R. A. & Rubinsztein, D. C. A molecular investigation of true dominance in Huntington's disease. J. Med. Genet. 36, 739–746 (1999).
  Article CAS Google Scholar
• Heiser, V. et al. Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: implications for Huntington's disease therapy. Proc. Natl Acad. Sci. USA 97, 6739–6744 (2000).
  Article CAS Google Scholar
• Gurney, M. E. et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264, 1772–1775 (1994).
  Article CAS Google Scholar
• Dal Canto, M. C. & Gurney, M. E. A low expressor line of transgenic mice carrying a mutant human Cu,Zn superoxide dismutase (SOD1) gene develops pathological changes that most closely resemble those in human amyotrophic lateral sclerosis. Acta Neuropathol. (Berl.) 93, 537–550 (1997).
  Article CAS Google Scholar
• Forlino, A., Porter, F. D., Lee, E. J., Westphal, H. & Marini, J. C. Use of the Cre/lox recombination system to develop a non-lethal knock-in murine model for osteogenesis imperfecta with an α1(I) G349C substitution. Variability in phenotype in BrtlIV mice. J. Biol. Chem. 274, 37923–37931 (1999).
  Article CAS Google Scholar
• Spring, K. et al. Atm knock-in mice harboring an in-frame deletion corresponding to the human ATM 7636del9 common mutation exhibit a variant phenotype. Cancer Res. 61, 4561–4568 (2001).
  CAS PubMed Google Scholar
• Bobet, J., Mooney, R. F. & Gordon, T. Force and stiffness of old dystrophic (mdx) mouse skeletal muscles. Muscle Nerve 21, 536–539 (1998).
  Article CAS Google Scholar
• Giovannini, M. et al. Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2. Genes Dev. 14, 1617–1630 (2000).
  CAS PubMed PubMed Central Google Scholar
• Li, H., Li, S. H., Yu, Z. X., Shelbourne, P. & Li, X. J. Huntingtin aggregate-associated axonal degeneration is an early pathological event in Huntington's disease mice. J. Neurosci. 21, 8473–8481 (2001).
  Article CAS Google Scholar
• Lin, C. H. et al. Neurological abnormalities in a knock-in mouse model of Huntington's disease. Hum. Mol. Genet. 10, 137–144 (2001).
  Article CAS Google Scholar
• Wheeler, V. C. et al. Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice. Hum. Mol. Genet. 9, 503–513 (2000).
  Article CAS Google Scholar
• Li, H., Li, S. H., Johnston, H., Shelbourne, P. F. & Li, X. J. Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity. Nature Genet. 25, 385–389 (2000).
  Article CAS Google Scholar
• Shelbourne, P. F. et al. A Huntington's disease CAG expansion at the murine Hdh locus is unstable and associated with behavioural abnormalities in mice. Hum. Mol. Genet. 8, 763–774 (1999).
  Article CAS Google Scholar
• Lorenzetti, D. et al. Repeat instability and motor incoordination in mice with a targeted expanded CAG repeat in the Sca1 locus. Hum. Mol. Genet. 9, 779–785 (2000).
  Article CAS Google Scholar
• MacDonald, M. E. et al. Evidence for the GluR6 gene associated with younger onset age of Huntington's disease. Neurology 53, 1330–1332 (1999).
  Article CAS Google Scholar
• Rubinsztein, D. C. et al. Genotypes at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease. Proc. Natl Acad. Sci. USA 94, 3872–3876 (1997).
  Article CAS Google Scholar
• Persichetti, F. et al. Huntington's disease CAG trinucleotide repeats in pathologically confirmed post-mortem brains. Neurobiol. Dis. 1, 159–166 (1994).
  Article CAS Google Scholar
• Kieburtz, K. et al. Trinucleotide repeat length and progression of illness in Huntington's disease. J. Med. Genet. 31, 872–874 (1994).
  Article CAS Google Scholar